John P Carulli

Title: John P Carulli: Innovator in Medical Risk Assessment and B Lymphocyte Activation

Introduction

John P Carulli is a notable inventor based in Southborough, MA (US). He has made significant contributions to the field of medical science, particularly in assessing risks associated with neurological conditions and developing novel polynucleotides.

Latest Patents

Carulli holds a total of 3 patents. His latest patents include a method for assessing the risk of Progressive Multifocal Leukoencephalopathy (PML), which focuses on evaluating a patient's likelihood of developing this serious neurological condition. Another significant patent involves polynucleotides encoding members of the human B lymphocyte activation antigen B7 family. This invention provides isolated BLAA polynucleotides and the associated polypeptides, along with antibodies that specifically bind to these polypeptides. The applications of this invention extend to the detection and treatment of various pathological states.

Career Highlights

Throughout his career, Carulli has worked with prominent companies, including Biogen Idec Ma Inc. His work has been instrumental in advancing medical research and innovation.

Collaborations

Carulli has collaborated with notable professionals in his field, including Cynthia A Green and Victor E Kotelianski. These collaborations have contributed to the development of his innovative patents and research.

Conclusion

John P Carulli is a distinguished inventor whose work in medical risk assessment and B lymphocyte activation has made a significant impact in the field. His contributions continue to influence research and development in medical science.